Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Buy
63
NTES Quote, Financials, Valuation and Earnings
Last price:
$100.81
Seasonality move
:
14.96%
Day range:
$100.74 - $102.48
52-week range:
$75.85 - $110.15
Dividend yield:
2.54%
P/E ratio:
15.89x
P/S ratio:
4.48x
P/B ratio:
3.45x
Volume:
558.5K
Avg. volume:
1.5M
1-year change:
-1.87%
Market cap:
$65.6B
Revenue:
$14.7B
EPS (TTM):
$6.40
Analysts' Opinion
-
Consensus RatingNetEase has received a consensus rating of Buy. The company's average rating is a Buy based on 21 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $122.16, NetEase has an estimated upside of 20.06% from its current price of $101.75.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $96.39 representing 100% downside risk from its current price of $101.75.
Fair Value
-
According to the consensus of 23 analysts, NetEase has 20.06% upside to fair value with a price target of $122.16 per share.
NTES vs. S&P 500
-
Over the past 5 trading days, NetEase has overperformed the S&P 500 by 1.32% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
NetEase does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
NetEase revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter NetEase reported revenues of $3.7B.
Earnings Growth
-
NetEase has grown year-over-year earnings for 1 quarter straight. In the most recent quarter NetEase reported earnings per share of $1.90.
Enterprise value:
48.9B
EV / Invested capital:
2.31x
Price / LTM sales:
4.48x
EV / EBIT:
11.87x
EV / Revenue:
3.33x
PEG ratio (5yr expected):
99.68x
EV / Free cash flow:
9.37x
Price / Operating cash flow:
12.59x
Enterprise value / EBITDA:
10.97x
Gross Profit (TTM):
$9.2B
Return On Assets:
15.67%
Net Income Margin (TTM):
28.2%
Return On Equity:
22.06%
Return On Invested Capital:
19.66%
Operating Margin:
29.24%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $14.3B | $14.6B | $14.7B | $3.8B | $3.7B | |
| Gross Profit | $7.8B | $8.9B | $9.2B | $2.3B | $2.3B | |
| Operating Income | $2.9B | $3.9B | $4.1B | $954.2M | $1.1B | |
| EBITDA | $3.4B | $4.4B | $4.5B | $1B | $1.2B | |
| Diluted EPS | $4.59 | $6.39 | $6.40 | $1.40 | $1.90 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $16.5B | $17.7B | $19.1B | $20.1B | $21B | |
| Total Assets | $21.7B | $24.1B | $25B | $26.2B | $26.8B | |
| Current Liabilities | $7.2B | $7.9B | $8.2B | $7.6B | $6.8B | |
| Total Liabilities | $7.4B | $8.5B | $9.3B | $8.2B | $7.3B | |
| Total Equity | $14.4B | $15.6B | $15.8B | $18.1B | $19.5B | |
| Total Debt | $3B | $3.2B | $4B | $2.8B | $1.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $4.1B | $5B | $5.5B | $1.7B | $1.8B | |
| Cash From Investing | -$1.1B | -$2.4B | $2.5B | -$1.5B | $2.9B | |
| Cash From Financing | -$1.5B | -$3B | -$3.8B | $641.9M | -$335.8M | |
| Free Cash Flow | $3.7B | $4.4B | $5.2B | $1.6B | $1.7B | |
NTES
Sector
Market Cap
$65.6B
$89.1M
Price % of 52-Week High
92.37%
65.29%
Dividend Yield
2.54%
0%
Shareholder Yield
4.85%
3.18%
1-Year Price Total Return
-1.87%
-13.28%
Beta (5-Year)
0.609
0.690
Dividend yield:
2.54%
Annualized payout:
$2.44
Payout ratio:
37.6%
Growth streak:
3 years
Technicals
8-day SMA
Buy
Level
$100.21
200-day SMA
Buy
Level
$91.62
Bollinger Bands (100)
Buy
Level
86.45 - 103.11
Chaikin Money Flow
Sell
Level
-34.2M
20-day SMA
Buy
Level
$101.23
Relative Strength Index (RSI14)
Buy
Level
51.44
ADX Line
Buy
Level
13.05
Williams %R
Neutral
Level
-42.9599
50-day SMA
Sell
Level
$101.81
MACD (12, 26)
Sell
Level
-0.28
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
110.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (6.8679)
Buy
CA Score
(Annual)
Level (1.3165)
Sell
Beneish M-Score
(Annual)
Level (-2.1641)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-4.471)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Founded in the late 1990s as an internet portal, NetEase has transformed into a leading force in the second-largest online game company gaming in China. While its initial success was built upon the massively multiplayer online role-playing game Fantasy Westward Journey, NetEase has expanded its portfolio with captivating franchises that resonate with both domestic and international players. Over the past decade, the company has created titles such as Justice, Identity V, Naraka: Bladepoint, and Eggy Party, all of which maintain significant player bases today. Beyond in-house development, the company also collaborates with likes of Microsoft and Marvel to create and publish games based on renowned IPs, including World of Warcraft, Diablo Immortal, and Marvel Rivals.
Stock Forecast FAQ
In the current month, NTES has received 21 Buy ratings 2 Hold ratings, and 0 Sell ratings. The NTES average analyst price target in the past 3 months is $122.16.
-
Where Will NetEase Stock Be In 1 Year?
According to analysts, the consensus estimate is that NetEase share price will rise to $122.16 per share over the next 12 months.
-
What Do Analysts Say About NetEase?
Analysts are divided on their view about NetEase share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that NetEase is a Sell and believe this share price will drop from its current level to $96.39.
-
What Is NetEase's Price Target?
The price target for NetEase over the next 1-year time period is forecast to be $122.16 according to 23 Wall Street analysts, 21 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is NTES A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for NetEase is a Buy. 21 of 23 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of NTES?
You can purchase shares of NetEase via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase NetEase shares.
-
What Is The NetEase Share Price Today?
NetEase was last trading at $100.81 per share. This represents the most recent stock quote for NetEase. Yesterday, NetEase closed at $101.75 per share.
-
How To Buy NetEase Stock Online?
In order to purchase NetEase stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is down 12.39% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
51
CAR alert for Mar 28
Avis Budget Group [CAR] is up 0.71% over the past day.
